Comparative study on mammography between triple negative and triple positive breast cancer

Chinese Journal of Radiology (China)

Volumn 46, Issue 5, 2012, Pages 420-424

  Cui, Chun Xiao ^a   Lin, Qing ^a   Yang, Qing ^a   Zhang, Chuan Yu ^a   Wang, Shao Hua ^a   Yu, Hua Long ^a   Duan, Feng ^a   Liu, Shi He ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Breast neoplasms; Comparative study; Mammography

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONSET AGE; TRIPLE NEGATIVE BREAST CANCER; TRIPLE POSITIVE BREAST CANCER; TUMOR CALCINOSIS; TUMOR VOLUME;

EID: 84864390051     PISSN: 10051201     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1005-1201.2012.05.009     Document Type: Article

References (15)

1. Thike A A, Cheok P Y, Jara-Lazaro A R, et al. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol, 2010, 23:123-133.
2. Bauer K R, Brown M, Cress R D, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 2007, 109:1721-1728.
3. Rakha E A, Reis-Filho J S, Ellis I O. Basal-like breast cancer; a critical review. J Clin Oncol, 2008, 26:2568-2581.
4. Cheang M C, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 2008, 14: 1368-1376.
5. Haffty B G, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 2006, 24: 5652-5657.
6. American College of Radiology (ACR). Breast imaging reporting and data system (BI-RADS). 4th ed. Reston: American College of Radiology, 2003: 1-259.
7. 2011, 45: 353-357.
8. Perou C M, Jeffrey S S, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA, 1999, 96:9212-9217.
9. Perou C M, Sorlie T, Eisen M B, et al. Molecular portraits of human breast tumours. Nature, 2000, 406: 747-752.
10. Rakha E A, E1-Sayed M E, Green A R, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109: 25-32.
11. 2003, 37:200-203.
12. Yang W T, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat, 2008, 111: 405-410.
13. Dogan B E, Gonzalez-Angulo A M, Gilcrease M, et al. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR, 2010, 194: 1160-1166.
14. Ko E S, Lee B H, Kim H A, et al. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol, 2010, 20: 1111-1117.
15. Evans A J, Pinder S E, Ellis J O, et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erB-2 oncogene expression. Clin Radiol, 1994, 49:559-562.